Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia

Clinical and Investigative Medicine

Volumn 31, Issue 1, 2008, Pages

  Zhong, WeiDe ^a,b   Peng, Jinyu ^c   He, HuiChan ^a   Wu, Dinglan ^c   Han, ZhaoDong ^a   Bi, XueCheng ^b   Dai, QiShan ^b  

^a GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b Nanfang Medical University   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; KI 67 ANTIGEN;

ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 39449105401     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Zhong WD, Li JL, HE HC, et al.. Study on the expression of BPH and prostate cancer related genes using real-time quantitative RT-PCR. Chinese Journal of Urology 2005;26:615-8.
2. Ostrander EA, Stanford JL. Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet 2000;67:1367-75.
3. Lumachi F, Marino E, lacobone M, Ravin G. Immunohistochemical markers PCNA-LI and Ki-67, and DNA index in patients with parathyroid carcinoma. Oral Presentations 2006;26:316-8
4. Derya Gumurdulu, Seyda Erdogan, Fazilet Kayaselcuk, et al. Expression of COX-2, PCNA, Ki-67 and p53 in gastrointestinal stromal tumors and its relationship with histopathological parameters. World J Gastroenterol 2007;13: 426-31
5. De Marzo AM, Coffey DS, Nelson WG. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology 1999;53:29-40.
6. Nemoto R, Kawamura H, Miyakawa I. Immunohistochemical detection of proliferating cell nuclear antigen (PCNA)/cyclin in human prostate adenocarcinoma. J Urol 1993;149:165-9.
7. F. Sandra, T. Mitsuyasu, N. Nakamura, et al. Immunohistochemical evaluation of PCNA and Ki-67 in amyeloblastoma. Oral Oncology 2001;37:193-8
8. Funaoka K, Arisue M, Kobayashi I, et al. Immunohistochemical detection of proliferating cell nuclear antigen (PCNA) in 23 cases of ameloblastoma. Oral Oncol, Eur J Cancer 1996; 32:328-32.
9. Sobin L, Wittekind C. TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York, 1997;59-62
10. Halvorsen OJ, Haukaa S, Hoisaeter PA. Maximum Ki - 67 staining in prostate cancer provides independent prognostic information after radical prostatectomy. Anticancer Res 2001; 21:4071-6.
11. Munoz E, Gomez F, Paz JI. Ki - 67 immunolabeling in pre-malignant lesions and carcinoma of the prostate. Histologic correlation and prognostic evaluation. Eur J Histochem 2003;47:123-8
12. Chapel F, Guettier C, Chastang C. Needle biopsy of hepatocellular carcinoma: assessment of prognostic contribution of histologic parameters including proliferating cell nuclear antigen labeling and correlations with clinical outcomes. Group d'Etude et de Traitement du Carcinoma Hepatocellulaire. Cancer 1996;77:864-71.
13. Spires S E, Banks E R , Davey D . Proliferating cell nuclear antigen in prostatic adenocarcinoma : correlation with established prognostic indicators Urology 1994;43:660.
14. Claudio PP, Zamparelli A, Garcia FU. Expression of Cell-cycle-regulated Protein PRb2/ P130, P107, P27-kip1, P53, mdm-2, and Ki-67(MIB-1) in prostatic gland adenocarcinoma. Clin Cancer Res 2002;8:1808-15.
15. Taylor LJ, Jackson TL, Reid JG, et al. The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps. BJOG 2003;110:794-78.
16. Ishida H, Sadahiro S, Suzuki T et al. Proliferative, infiltrative, and metastatic activities in colorectal tumors assessed by MIB-1 antibody. Oncol Rep 2003;10:1741-5.
17. Graziano F, Cascinu S. Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? Ann Oncol 2003;14: 1026-38.
18. Bantis A, Giannopoulos A, Gonidi M. Expression of P120 ,Ki - 67and PCNA as proliferation biomarkers in imprint smears of prostate carcinoma and their prognostic smears of prostate carcinoma and their prognostic value. Cytopathology 2004;15:25-31.
19. Ray R, Tahan SR, Andrews C, Goldman H. Stromal tumors of the stomach: prognostic value of the PCNA index. Mod Pathol 1994;7:26-30
20. Sbaschnig RJ, Cunningham RE, Sobin LH, O'Leary TJ. Proliferating-cell nuclear antigen immunocytochemistry in the evaluation of gastrointestinal smooth-muscle tumors. Mod Pathol 1994;7:78